intranasal

The Drugs Controller General of India (DCGI) on Friday granted permission to BharatBiotech for intranasal booster dose trials. The sources revealed earlier this month that India is expected to get an intranasal booster vaccine…

Hyderabad-based Bharat Biotech has submitted an application to the country's drug regulator to conduct a late-stage trial for a booster dose of its intranasal coronavirus vaccine, reported news agency ANI on Monday, citing a…

tech2 News StaffAug 02, 2021 08:07:43 ISTAfter releasing the results from Phase 2 human trials of its COVID-19 vaccine Covaxin in India, Bharat Biotech has now begun testing an intranasal vaccine in different parts of the country. The Phase…